Rockefeller Capital Management’s Emergent Biosolutions EBS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.77K	Buy	1,056 +861	+442%	+$8.92K	﹤0.01%	4051
2025 Q4	$2.41K	Buy	+195	New	+$2.09K	﹤0.01%	4270
2023 Q1	–	Sell	-101	Closed	-$1K	–	2492
2022 Q4	$1K	Sell	101 -56	-36%	-$867	﹤0.01%	3669
2022 Q3	$3K	Sell	157 -70	-31%	-$1.95K	﹤0.01%	3474
2022 Q2	$7K	Sell	227 -16	-7%	-$546	﹤0.01%	3288
2022 Q1	$9K	Buy	+243	New	+$10.7K	﹤0.01%	3099
2021 Q4	–	Sell	-200	Closed	-$10K	–	3821
2021 Q3	$10K	Sell	200 -12	-6%	-$727	﹤0.01%	2883
2021 Q2	$13K	Buy	212 +12	+6%	+$771	﹤0.01%	2661
2021 Q1	$18K	Sell	200 -600	-75%	-$61.5K	﹤0.01%	2323
2020 Q4	$71K	Sell	800 -119	-13%	-$10.9K	﹤0.01%	1565
2020 Q3	$94K	Sell	919 -44	-5%	-$4.74K	﹤0.01%	1281
2020 Q2	$76K	Buy	963 +510	+113%	+$38K	﹤0.01%	1269
2020 Q1	$26K	Buy	453 +240	+113%	+$13.8K	﹤0.01%	1423
2019 Q4	$11K	Hold	213	–	–	﹤0.01%	1576
2019 Q3	$11K	Sell	213 -14	-6%	-$652	﹤0.01%	1387
2019 Q2	$11K	Sell	227 -136	-37%	-$6.52K	﹤0.01%	1198
2019 Q1	$18K	Buy	+363	New	+$21.4K	﹤0.01%	1280